Viewing StudyNCT00130442



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00130442
Status: COMPLETED
Last Update Posted: 2022-06-23
First Post: 2005-08-12

Brief Title: Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Sponsor: Cellxpert Biotechnology Corp
Organization: Cellxpert Biotechnology Corp

Conditions & Keywords Data

Conditions:
Name
Melanoma
Keywords:
Name View
PI-88 View
phase II View
metastatic melanoma View
dacarbazine View
combination View